Cargando…
Current status and considerations on biosimilar in China
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479963/ http://dx.doi.org/10.1186/1479-5876-10-S2-A38 |
_version_ | 1782247486364057600 |
---|---|
author | Wang, Junzhi |
author_facet | Wang, Junzhi |
author_sort | Wang, Junzhi |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3479963 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34799632012-10-26 Current status and considerations on biosimilar in China Wang, Junzhi J Transl Med Meeting Abstract BioMed Central 2012-10-17 /pmc/articles/PMC3479963/ http://dx.doi.org/10.1186/1479-5876-10-S2-A38 Text en Copyright ©2012 Wang; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Meeting Abstract Wang, Junzhi Current status and considerations on biosimilar in China |
title | Current status and considerations on biosimilar in China |
title_full | Current status and considerations on biosimilar in China |
title_fullStr | Current status and considerations on biosimilar in China |
title_full_unstemmed | Current status and considerations on biosimilar in China |
title_short | Current status and considerations on biosimilar in China |
title_sort | current status and considerations on biosimilar in china |
topic | Meeting Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479963/ http://dx.doi.org/10.1186/1479-5876-10-S2-A38 |
work_keys_str_mv | AT wangjunzhi currentstatusandconsiderationsonbiosimilarinchina |